Astra Otoparts - AUTO IJ - Buy - Associates and trading business yield fruit
Astra Otoparts continues to show resilient earnings, which were driven by its trading
Automobiles n Components JT GH 782 30th Aug, 2024
Maintain Buy with lower TP of IDR6,000
In autos, as discussed in our previous Anchor Report, Shifting gears — the value chain mostly goes to parts, manufacturers, distributors and dealers. Indeed, Astra has consolidated most of its dealerships, while the remaining parts of the value chain are co-owned with other stakeholders (mostly Japanese partners, according to the company). We notice the drivers of Astra’s earnings since 2016-2023 have been the heavy equipment segment (UNTR IJ, Not rated) and fincos, and thus it could be a challenge for future earnings growth to be as strong as the historical level. We still like Astra given its strong dealership franchise in Indonesia and its historical strong track record of market share in 4W and 2W.
Breaking down Astra’s earnings – superb growth from heavy equipment and fincos
Consolidated net profit grew from IDR15tn in 2016 to IDR34tn in 2023, where IDR17tn of the IDR19tn earnings increase came from UNTR IJ (delta IDR10tn) and fincos profit (delta IDR7tn), while 4W business declined slightly and 2W increased slightly, in our view. We believe this is because the autos business is challenging across the value chain, particularly in the dealers segment.
Incoming competition in 4W and new segment in 2W
We are seeing more evidence that 4W electric vehicles are gaining market share (see Fig. 9), with BYD (1211 HK, Buy) gaining 2.5% market share in just two months — surpassing Hyundai (005380 KS, Buy) and Wuling (305 HK, Not rated) according to Gaikindo. In 2W, we are seeing more traction on the sales of electric bicycles (e-bikes) — a cheaper version of 2W, but they do not require license plates (pricing start at USD200 vs USD1,200 for a conventional motorcycle) — which would be a threat to low-segment motorcycles, in our view. Our observations suggest students in local schools are using e-bikes as a driving option (see Fig. 3).
Trim earnings and cut TP to IDR6,000 but maintain Buy, implying 19% upside
We cut 2024F/2025F earnings by 3.6%/4.6% to reflect the hiccups in the autos segment. Our TP of IDR6,000 is derived from an unchanged SOTP valuation (implying 2024F P/E of 7x – previously 8x), finco (target 2024F P/B of 2.2x), the value of its listed subsidiaries using Bloomberg consensus TPs discounted by 30%, toll roads (NAV), and also equity investments using book value. Our TP implies 8.1x 2024F forward P/E (currently: 6.8x P/E). Downside risks: 1) faster-than-expected sales of ex-Astra brands (especially Chinese’s), 2) sluggish purchasing power thus hurting local sales, 3) failure to maximize cash utilization, and 4) margin pressure from auto value chain.
Year-end 31 Dec | FY23 | FY24F | FY25F | FY26F | |||
Currency (IDR) | Actual | Old | New | Old | New | Old | New |
Revenue (bn) | 316,565 | 311,817 | 310,080 | 320,374 | 317,458 | 330,024 | 323,873 |
Reported net profit (bn) | 33,839 | 30,970 | 29,842 | 32,374 | 30,893 | 33,450 | 31,758 |
Normalised net profit (bn) | 33,839 | 30,970 | 29,842 | 32,374 | 30,893 | 33,450 | 31,758 |
FD normalised EPS | 835.87 | 764.99 | 737.14 | 799.69 | 763.09 | 826.26 | 784.47 |
FD norm. EPS growth (%) | 16.9 | -8.5 | -11.8 | 4.5 | 3.5 | 3.3 | 2.8 |
FD normalised P/E (x) | 6.0 | – | 6.8 | – | 6.6 | – | 6.4 |
EV/EBITDA (x) | 4.9 | – | 5.4 | – | 5.4 | – | 5.4 |
Price/book (x) | 1.0 | – | 1.0 | – | 0.9 | – | 0.8 |
Dividend yield (%) | 19.0 | – | 10.3 | – | 6.6 | – | 6.8 |
ROE (%) | 17.3 | 14.9 | 14.7 | 14.3 | 14.3 | 13.6 | 13.6 |
Net debt/equity (%) | 25.8 | 17.3 | 23.3 | 14.7 | 22.3 | 13.2 | 21.4 |
Income statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY22 | FY23 | FY24F | FY25F | FY26F | ||||||||||||||
Revenue | 301,379 | 316,565 | 310,080 | 317,458 | 323,873 | ||||||||||||||
Cost of goods sold | -231,291 | -243,255 | -242,418 | -248,498 | -253,486 | ||||||||||||||
Gross profit | 70,088 | 73,310 | 67,663 | 68,960 | 70,386 | ||||||||||||||
SG&A | -27,887 | -29,042 | -29,308 | -30,154 | -30,833 | ||||||||||||||
Employee share expense | |||||||||||||||||||
Operating profit | 42,201 | 44,268 | 38,355 | 38,806 | 39,553 | ||||||||||||||
EBITDA | 56,001 | 53,405 | 47,799 | 48,871 | 50,253 | ||||||||||||||
Depreciation | -13,800 | -9,137 | -9,444 | -10,065 | -10,700 | ||||||||||||||
Amortisation | |||||||||||||||||||
EBIT | 42,201 | 44,268 | 38,355 | 38,806 | 39,553 | ||||||||||||||
Net interest expense | 428 | -59 | -1,263 | -550 | -1,052 | ||||||||||||||
Associates & JCEs | 8,231 | 9,499 | 10,236 | 10,836 | 11,365 | ||||||||||||||
Other income | -470 | 1,021 | 1,351 | 1,071 | 1,485 | ||||||||||||||
Earnings before tax | 50,390 | 54,729 | 48,679 | 50,163 | 51,351 | ||||||||||||||
Income tax | -9,970 | -10,228 | -9,611 | -9,832 | -9,996 | ||||||||||||||
Net profit after tax | 40,420 | 44,501 | 39,068 | 40,331 | 41,355 | ||||||||||||||
Minority interests | -11,476 | -10,662 | -9,226 | -9,438 | -9,597 | ||||||||||||||
Other items | |||||||||||||||||||
Preferred dividends | |||||||||||||||||||
Normalised NPAT | 28,944 | 33,839 | 29,842 | 30,893 | 31,758 | ||||||||||||||
Extraordinary items | |||||||||||||||||||
Reported NPAT | 28,944 | 33,839 | 29,842 | 30,893 | 31,758 | ||||||||||||||
Dividends | -15,295 | -38,707 | -20,949 | -13,429 | -13,902 | ||||||||||||||
Transfer to reserves | 13,649 | -4,868 | 8,894 | 17,464 | 17,856 | ||||||||||||||
Valuations and ratios | |||||||||||||||||||
Reported P/E (x) | 7.0 | 6.0 | 6.8 | 6.6 | 6.4 | ||||||||||||||
Normalised P/E (x) | 7.0 | 6.0 | 6.8 | 6.6 | 6.4 | ||||||||||||||
FD normalised P/E (x) | 7.0 | 6.0 | 6.8 | 6.6 | 6.4 | ||||||||||||||
Dividend yield (%) | 7.5 | 19.0 | 10.3 | 6.6 | 6.8 | ||||||||||||||
Price/cashflow (x) | 4.7 | 6.2 | 4.3 | 5.8 | 5.7 | ||||||||||||||
Price/book (x) | 1.1 | 1.0 | 1.0 | 0.9 | 0.8 | ||||||||||||||
EV/EBITDA (x) | 4.1 | 4.9 | 5.4 | 5.4 | 5.4 | ||||||||||||||
EV/EBIT (x) | 5.2 | 5.7 | 6.4 | 6.5 | 6.6 | ||||||||||||||
Gross margin (%) | 23.3 | 23.2 | 21.8 | 21.7 | 21.7 | ||||||||||||||
EBITDA margin (%) | 18.6 | 16.9 | 15.4 | 15.4 | 15.5 | ||||||||||||||
EBIT margin (%) | 14.0 | 14.0 | 12.4 | 12.2 | 12.2 | ||||||||||||||
Net margin (%) | 9.6 | 10.7 | 9.6 | 9.7 | 9.8 | ||||||||||||||
Effective tax rate (%) | 19.8 | 18.7 | 19.7 | 19.6 | 19.5 | ||||||||||||||
Dividend payout (%) | 52.8 | 114.4 | 70.2 | 43.5 | 43.8 | ||||||||||||||
ROE (%) | 15.9 | 17.3 | 14.7 | 14.3 | 13.6 | ||||||||||||||
ROA (pretax %) | 15.4 | 14.2 | 11.8 | 11.4 | 10.9 | ||||||||||||||
Growth (%) | |||||||||||||||||||
Revenue | 29.1 | 5.0 | -2.0 | 2.4 | 2.0 | ||||||||||||||
EBITDA | 65.0 | -4.6 | -10.5 | 2.2 | 2.8 | ||||||||||||||
Normalised EPS | 43.3 | 16.9 | -11.8 | 3.5 | 2.8 | ||||||||||||||
Normalised FDEPS | 43.3 | 16.9 | -11.8 | 3.5 | 2.8 | ||||||||||||||
Source: Company data, Verdhana estimates |
Cashflow statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY22 | FY23 | FY24F | FY25F | FY26F | ||||||||||||||
EBITDA | 56,001 | 53,405 | 47,799 | 48,871 | 50,253 | ||||||||||||||
Change in working capital | -2,295 | -6,472 | 12,300 | 101 | 45 | ||||||||||||||
Other operating cashflow | -10,831 | -14,260 | -12,933 | -13,854 | -14,448 | ||||||||||||||
Cashflow from operations | 42,875 | 32,673 | 47,166 | 35,119 | 35,850 | ||||||||||||||
Capital expenditure | -29,651 | -39,441 | -25,913 | -26,530 | -27,066 | ||||||||||||||
Free cashflow | 13,224 | -6,768 | 21,253 | 8,589 | 8,784 | ||||||||||||||
Reduction in investments | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Net acquisitions | |||||||||||||||||||
Dec in other LT assets | |||||||||||||||||||
Inc in other LT liabilities | |||||||||||||||||||
Adjustments | 8,257 | 3,708 | 2,631 | 3,149 | 3,124 | ||||||||||||||
CF after investing acts | 21,481 | -3,060 | 23,884 | 11,737 | 11,908 | ||||||||||||||
Cash dividends | -15,295 | -38,707 | -20,949 | -13,429 | -13,902 | ||||||||||||||
Equity issue | |||||||||||||||||||
Debt issue | -6,186 | 22,170 | 6,493 | 9,752 | 10,222 | ||||||||||||||
Convertible debt issue | |||||||||||||||||||
Others | |||||||||||||||||||
CF from financial acts | -21,481 | -16,537 | -14,456 | -3,677 | -3,680 | ||||||||||||||
Net cashflow | 0 | -19,597 | 9,428 | 8,060 | 8,229 | ||||||||||||||
Beginning cash | 61,581 | 61,581 | 41,984 | 51,412 | 59,472 | ||||||||||||||
Ending cash | 61,581 | 41,984 | 51,412 | 59,472 | 67,701 | ||||||||||||||
Ending net debt | 9,140 | 51,326 | 48,391 | 50,082 | 52,076 | ||||||||||||||
Balance sheet (IDRbn) | |||||||||||||||||||
As at 31 Dec | FY22 | FY23 | FY24F | FY25F | FY26F | ||||||||||||||
Cash & equivalents | 61,581 | 41,984 | 51,412 | 59,472 | 67,701 | ||||||||||||||
Marketable securities | |||||||||||||||||||
Accounts receivable | 35,001 | 33,688 | 36,012 | 36,868 | 37,613 | ||||||||||||||
Inventories | 36,626 | 45,537 | 33,674 | 34,518 | 35,211 | ||||||||||||||
Other current assets | 16,933 | 17,239 | 16,534 | 16,920 | 17,229 | ||||||||||||||
Total current assets | 150,141 | 138,448 | 137,631 | 147,779 | 157,755 | ||||||||||||||
LT investments | 46,725 | 61,348 | 64,419 | 67,670 | 71,079 | ||||||||||||||
Fixed assets | 94,697 | 114,374 | 120,434 | 126,242 | 131,735 | ||||||||||||||
Goodwill | 5,016 | 5,310 | 5,310 | 5,310 | 5,310 | ||||||||||||||
Other intangible assets | |||||||||||||||||||
Other LT assets | 116,718 | 126,199 | 144,929 | 164,960 | 185,962 | ||||||||||||||
Total assets | 413,297 | 445,679 | 472,723 | 511,960 | 551,841 | ||||||||||||||
Short-term debt | 34,669 | 39,061 | 45,554 | 55,306 | 65,528 | ||||||||||||||
Accounts payable | 37,644 | 40,529 | 39,455 | 40,445 | 41,256 | ||||||||||||||
Other current liabilities | 46,885 | 45,432 | 48,562 | 49,761 | 50,741 | ||||||||||||||
Total current liabilities | 119,198 | 125,022 | 133,570 | 145,511 | 157,525 | ||||||||||||||
Long-term debt | 36,052 | 54,249 | 54,249 | 54,249 | 54,249 | ||||||||||||||
Convertible debt | |||||||||||||||||||
Other LT liabilities | 14,327 | 15,990 | 16,366 | 16,760 | 17,174 | ||||||||||||||
Total liabilities | 169,577 | 195,261 | 204,185 | 216,520 | 228,948 | ||||||||||||||
Minority interest | 51,578 | 51,778 | 61,004 | 70,443 | 80,039 | ||||||||||||||
Preferred stock | |||||||||||||||||||
Common stock | |||||||||||||||||||
Retained earnings | 181,523 | 188,997 | 197,891 | 215,354 | 233,211 | ||||||||||||||
Proposed dividends | |||||||||||||||||||
Other equity and reserves | 10,619 | 9,643 | 9,643 | 9,643 | 9,643 | ||||||||||||||
Total shareholders' equity | 192,142 | 198,640 | 207,534 | 224,997 | 242,854 | ||||||||||||||
Total equity & liabilities | 413,297 | 445,679 | 472,723 | 511,960 | 551,841 | ||||||||||||||
Liquidity (x) | |||||||||||||||||||
Current ratio | 1.26 | 1.11 | 1.03 | 1.02 | 1.00 | ||||||||||||||
Interest cover | – | 750.3 | 30.4 | 70.6 | 37.6 | ||||||||||||||
Leverage | |||||||||||||||||||
Net debt/EBITDA (x) | 0.16 | 0.96 | 1.01 | 1.02 | 1.04 | ||||||||||||||
Net debt/equity (%) | 4.8 | 25.8 | 23.3 | 22.3 | 21.4 | ||||||||||||||
Per share | |||||||||||||||||||
Reported EPS (IDR) | 714.96 | 835.87 | 737.14 | 763.09 | 784.47 | ||||||||||||||
Norm EPS (IDR) | 714.96 | 835.87 | 737.14 | 763.09 | 784.47 | ||||||||||||||
FD norm EPS (IDR) | 714.96 | 835.87 | 737.14 | 763.09 | 784.47 | ||||||||||||||
BVPS (IDR) | 4,746.17 | 4,906.68 | 5,126.37 | 5,557.75 | 5,998.83 | ||||||||||||||
DPS (IDR) | 377.81 | 956.12 | 517.46 | 331.71 | 343.39 | ||||||||||||||
Activity (days) | |||||||||||||||||||
Days receivable | 37.1 | 39.6 | 41.1 | 41.9 | 42.0 | ||||||||||||||
Days inventory | 48.9 | 61.6 | 59.8 | 50.1 | 50.2 | ||||||||||||||
Days payable | 49.5 | 58.6 | 60.4 | 58.7 | 58.8 | ||||||||||||||
Cash cycle | 36.5 | 42.6 | 40.6 | 33.3 | 33.4 | ||||||||||||||
Source: Company data, Verdhana estimates |
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Reduced from IDR 6,800 | IDR 6,000 |
Closing price 28 August 2024 | IDR 5,025 |
Implied upside | +19.4% |
Market Cap (USD mn) | 13,192.6 |
ADT (USD mn) | 18.6 |
Jupriadi Tan (jupriadi.tan@verdhana.id) and
Gerald Hugo (gerald.hugo@verdhana.id)